R Arnone - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R Arnone

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Bioorganic & Medicinal Chemistry Letters|July 8, 2011

Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroupJohn C Stellwagen, George M Adjabeng, Marc R Arnone, et al.

ACS Medicinal Chemistry Letters|June 6, 2014

Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven TumorsTara R Rheault, John C Stellwagen, George M Adjabeng, et al.

Journal of Medicinal Chemistry|November 13, 2004

Synthesis and biological evaluation of 1-aryl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of cyclin-dependent kinasesJay A Markwalder, Marc R Arnone, Pamela A Benfield, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Bioorganic & Medicinal Chemistry Letters|July 8, 2011

Development of potent B-RafV600E inhibitors containing an arylsulfonamide headgroupJohn C Stellwagen, George M Adjabeng, Marc R Arnone, et al.

ACS Medicinal Chemistry Letters|June 6, 2014

Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven TumorsTara R Rheault, John C Stellwagen, George M Adjabeng, et al.

Journal of Medicinal Chemistry|November 13, 2004

Synthesis and biological evaluation of 1-aryl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of cyclin-dependent kinasesJay A Markwalder, Marc R Arnone, Pamela A Benfield, et al.

Pageof 3